Sponsors (8)
Official title: To direct the Secretary of Commerce to promote competitiveness in biomanufacturing in the United States, identify supply-chain and commercialization vulnerabilities relating to critical biomanufacturing inputs and domestic production capacity, improve transparency regarding Federal processes applicable to biomanufactured products, and for other purposes.
Introduced August 27, 2026 by Robert E. Latta · Last progress August 27, 2026
The bill centralizes Commerce-led coordination and public resources to strengthen domestic biomanufacturing and supply‑chain resilience, at the cost of added federal administrative expense and risks of industry disruption or sensitive information exposure.
Small biomanufacturers, researchers, and taxpayers gain stronger domestic supply‑chain resilience because the Commerce Department will lead biennial assessments and prioritized action plans to identify chokepoints, substitutes, and diversification opportunities.
Small businesses and state/local stakeholders get easier access to federal commercialization support because the bill creates a clear federal point of contact and a consolidated public web resource for agency guidance and navigation.
Small and early‑stage biomanufacturers can adopt industry‑led voluntary best practices more quickly, helping them improve commercialization, quality, and scale-up processes.
Small biomanufacturers and downstream customers may face higher costs and supply disruptions because prioritizing reduced reliance on foreign adversaries can force reshoring or supplier changes with higher prices and longer lead times.
Taxpayers bear higher administrative costs because federal resources and staff will be required to run assessments, maintain the web resource, and coordinate interagency efforts.
Small businesses and researchers may withhold nonpublic supply‑chain information despite confidentiality protections, reducing the accuracy and usefulness of assessments and public guidance.
Based on analysis of 2 sections of legislative text.
Requires Commerce to designate a senior official to coordinate federal biomanufacturing competitiveness, assess supply‑chain vulnerabilities, and maintain a public resource for stakeholders.
Designates a senior Commerce Department official to lead federal efforts on biomanufacturing competitiveness, supply-chain resilience, and commercial scale-up of biomanufactured products. Requires a government-wide assessment of federal processes, supply-chain vulnerabilities (including dependencies tied to foreign adversaries), domestic production capacity and inputs, and voluntary consultations with private-sector and other non‑Federal stakeholders. Directs Commerce to coordinate with relevant agencies (including HHS/FDA and EPA), maintain a public web resource linking guidance and contacts, and serve as a single point of referral for non‑Federal entities seeking federal information about biomanufacturing-related processes and resources. The official must be designated within 1 year and complete a specified assessment and reporting workstream as required by the Act.